186 related articles for article (PubMed ID: 16295502)
1. Tissue concentration, systemic distribution and toxicity of clofazimine--an autopsy study.
Jadhav MV; Sathe AG; Deore SS; Patil PG; Joshi NG
Indian J Pathol Microbiol; 2004 Apr; 47(2):281-3. PubMed ID: 16295502
[TBL] [Abstract][Full Text] [Related]
2. Tissue distribution and deposition of clofazimine in rat following subchronic treatment with or without rifampicin.
Mamidi NV; Rajasekhar A; Prabhakar MC; Krishna DR
Arzneimittelforschung; 1995 Sep; 45(9):1029-31. PubMed ID: 7488306
[TBL] [Abstract][Full Text] [Related]
3. [Persistent type 2 lepra reaction (erythema nodosum) and clofazimine-induced lethal enteropathy].
Rodríguez G; Pinto R; López F; Gómez Y
Biomedica; 2009 Mar; 29(1):18-24. PubMed ID: 19753835
[TBL] [Abstract][Full Text] [Related]
4. Does clofazimine prevent erythema nodosum leprosum (ENL) in leprosy? A retrospective study, comparing the experience of multibacillary patients receiving either 12 or 24 months WHO-MDT.
Balagon M; Saunderson PR; Gelber RH
Lepr Rev; 2011 Sep; 82(3):213-21. PubMed ID: 22125929
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for erythema nodosum leprosum.
Manandhar R; LeMaster JW; Roche PW
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):270-8. PubMed ID: 10575406
[TBL] [Abstract][Full Text] [Related]
6. Erythema leprosum--after treatment of Lepromatous Leprosy.
Eickelmann M; Steinhoff M; Metze D; Tomimori-Yamashita J; Sunderkötter C
J Dtsch Dermatol Ges; 2010 Jun; 8(6):450-3. PubMed ID: 19922466
[TBL] [Abstract][Full Text] [Related]
7. Tissue distribution and deposition of clofazimine in mice following oral administration with or without isoniazid.
Venkatesan K; Deo N; Gupta UD
Arzneimittelforschung; 2007; 57(7):472-4. PubMed ID: 17803061
[TBL] [Abstract][Full Text] [Related]
8. Excretion of clofazimine in human milk in leprosy patients.
Venkatesan K; Mathur A; Girdhar A; Girdhar BK
Lepr Rev; 1997 Sep; 68(3):242-6. PubMed ID: 9364825
[TBL] [Abstract][Full Text] [Related]
9. Intra-abdominal, crystal-storing histiocytosis due to clofazimine in a patient with lepromatous leprosy and concurrent carcinoma of the colon.
Pais AV; Pereira S; Garg I; Stephen J; Antony M; Inchara YK
Lepr Rev; 2004 Jun; 75(2):171-6. PubMed ID: 15282969
[TBL] [Abstract][Full Text] [Related]
10. Does clofazimine (B663) reach Mycobacterium leprae persisting in Schwann cells and endothelial cells of endoneurial blood vessels in peripheral nerves?
Kumar V
Microsc Res Tech; 2008 Aug; 71(8):614-8. PubMed ID: 18567015
[TBL] [Abstract][Full Text] [Related]
11. Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy.
Goulart IM; Reis AC; De Rezende TM; Borges AS; Ferreira MS; Nishioka SA
Lepr Rev; 2005 Jun; 76(2):167-9. PubMed ID: 16038251
[No Abstract] [Full Text] [Related]
12. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
Feuth M; Brandsma JW; Faber WR; Bhattarai B; Feuth T; Anderson AM
Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and relative bioavailability of clofazimine in relation to food, orange juice and antacid.
Nix DE; Adam RD; Auclair B; Krueger TS; Godo PG; Peloquin CA
Tuberculosis (Edinb); 2004; 84(6):365-73. PubMed ID: 15525560
[TBL] [Abstract][Full Text] [Related]
14. Clofazimine induced enteropathy--a case highlighting the importance of drug induced disease in differential diagnosis.
Mathew BS; Pulimood AB; Prasanna CG; Ramakrishna BS; Chandy SJ
Trop Gastroenterol; 2006; 27(2):87-8. PubMed ID: 17089619
[TBL] [Abstract][Full Text] [Related]
15. Clofazimine induced nail changes.
Dixit VB; Chaudhary SD; Jain VK
Indian J Lepr; 1989 Oct; 61(4):476-8. PubMed ID: 2621382
[TBL] [Abstract][Full Text] [Related]
16. Chronic recurrent ENL, steroid dependent: long-term treatment with high dose clofazimine.
Schreuder PA; Naafs B
Lepr Rev; 2003 Dec; 74(4):386-9. PubMed ID: 14750585
[No Abstract] [Full Text] [Related]
17. Decreases in mean hemoglobin and serum albumin values in erythema nodosum leprosum and lepromatous leprosy.
Rea TH
Int J Lepr Other Mycobact Dis; 2001 Dec; 69(4):318-27. PubMed ID: 12035293
[TBL] [Abstract][Full Text] [Related]
18. Necrotic erythema nodosum leprosum with oral mucosal involvement.
Swain JP; Soud A; Agarwal SK
Indian J Lepr; 2008; 80(2):175-8. PubMed ID: 19425513
[TBL] [Abstract][Full Text] [Related]
19. Using methotrexate to treat patients with ENL unresponsive to steroids and clofazimine: a report on 9 patients.
Hossain D
Lepr Rev; 2013 Mar; 84(1):105-12. PubMed ID: 23741889
[TBL] [Abstract][Full Text] [Related]
20. Characterization of clofazimine metabolites in humans by HPLC-electrospray mass spectrometry.
Krishna DR; Mamidi RN; Hofmann U; Prabhakar CM
Arzneimittelforschung; 1997 Mar; 47(3):303-6. PubMed ID: 9105550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
